Australia markets close in 4 hours 3 minutes

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
19.92+0.82 (+4.29%)
At close: 04:00PM EDT
20.28 +0.36 (+1.81%)
After hours: 05:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 288.13M
Enterprise value 172.21M
Trailing P/E 0.53
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.54
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.42

Trading information

Stock price history

Beta (5Y monthly) 2.22
52-week change 329.93%
S&P500 52-week change 323.28%
52-week high 331.01
52-week low 34.00
50-day moving average 322.91
200-day moving average 316.18

Share statistics

Avg vol (3-month) 3126.25k
Avg vol (10-day) 3315.06k
Shares outstanding 515.09M
Implied shares outstanding 615.09M
Float 88.92M
% held by insiders 14.96%
% held by institutions 188.36%
Shares short (28 June 2024) 4832.08k
Short ratio (28 June 2024) 44.87
Short % of float (28 June 2024) 45.59%
Short % of shares outstanding (28 June 2024) 45.52%
Shares short (prior month 31 May 2024) 4684.82k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 304 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-33.05%
Return on equity (ttm)-53.63%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -68.86M
Net income avi to common (ttm)-63.93M
Diluted EPS (ttm)-61.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)118.47M
Total cash per share (mrq)7.85
Total debt (mrq)2.55M
Total debt/equity (mrq)2.26%
Current ratio (mrq)13.49
Book value per share (mrq)7.51

Cash flow statement

Operating cash flow (ttm)-57.47M
Levered free cash flow (ttm)-35.58M